Stratos Wealth Partners »

Carisma Therapeutics shares owned by Stratos Wealth Partners

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Stratos Wealth Partners from 13F filings

Historical chart of Stratos Wealth Partners investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Stratos Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Stratos Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 13k 2.27
2023-03-31 $62k 20k 3.10

More positions owned by Stratos Wealth Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Extend Mkt Etf (VXF)
Ishares Tr Core Msci Intl (IDEV)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Stratos Wealth Partners

Top funds holding Carisma Therapeutics

Tpg Gp A
Vanguard Group
Bank of New York Mellon
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Dimensional Fund Advisors
Blodgett Wealth Advisors
Two Sigma Investments
Jpmorgan Chase & Co
SG Americas Securities
American International

View all funds holding Carisma Therapeutics